Literature DB >> 10146892

Economic costs of theophylline toxicity.

R A Hamilton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 10146892     DOI： 10.2165/00019053-199405030-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  5 in total

1.  Confidence intervals rather than P values: estimation rather than hypothesis testing.

Authors:  M J Gardner; D G Altman
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-15

2.  Hospital admission for xanthine toxicity.

Authors:  L E Derby; S S Jick; J C Langlois; L E Johnson; H Jick
Journal:  Pharmacotherapy       Date:  1990       Impact factor: 4.705

3.  Treatment of theophylline toxicity with oral activated charcoal.

Authors:  C N Sessler; F L Glauser; K R Cooper
Journal:  Chest       Date:  1985-03       Impact factor: 9.410

Review 4.  Evaluation of theophylline overdoses and toxicities.

Authors:  F P Paloucek; K A Rodvold
Journal:  Ann Emerg Med       Date:  1988-02       Impact factor: 5.721

5.  Incidence and cost of hospital admissions secondary to drug interactions involving theophylline.

Authors:  R A Hamilton; T Gordon
Journal:  Ann Pharmacother       Date:  1992-12       Impact factor: 3.154
  5 in total
  3 in total

Review 1.  Counting the costs of drug-related adverse events.

Authors:  T J White; A Arakelian; J P Rho
Journal:  Pharmacoeconomics       Date:  1999-05       Impact factor: 4.981

2.  Clarifying the costs of theophylline toxicity.

Authors:  A S Zbrozek
Journal:  Pharmacoeconomics       Date:  1994-11       Impact factor: 4.981

Review 3.  Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?

Authors:  T D Holimon; C C Chafin; T H Self
Journal:  Drugs       Date:  2001       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.